

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.38474392 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 6.58758395 |
| 3 | intestinal absorption (GO:0050892) | 6.33978101 |
| 4 | high-density lipoprotein particle remodeling (GO:0034375) | 6.09334423 |
| 5 | regulation of triglyceride catabolic process (GO:0010896) | 5.92842062 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.92308635 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.92308635 |
| 8 | reverse cholesterol transport (GO:0043691) | 5.90629795 |
| 9 | phospholipid efflux (GO:0033700) | 5.81850911 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.79100763 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.79100763 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 5.76234460 |
| 13 | urea metabolic process (GO:0019627) | 5.55356688 |
| 14 | urea cycle (GO:0000050) | 5.55356688 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.31604996 |
| 16 | protein-lipid complex remodeling (GO:0034368) | 5.31509880 |
| 17 | macromolecular complex remodeling (GO:0034367) | 5.31509880 |
| 18 | plasma lipoprotein particle remodeling (GO:0034369) | 5.31509880 |
| 19 | plasma lipoprotein particle assembly (GO:0034377) | 5.20880270 |
| 20 | negative regulation of cholesterol transport (GO:0032375) | 5.19120014 |
| 21 | negative regulation of sterol transport (GO:0032372) | 5.19120014 |
| 22 | cholesterol efflux (GO:0033344) | 5.18378165 |
| 23 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.10706441 |
| 24 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.10706441 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.03560508 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.99760985 |
| 27 | drug catabolic process (GO:0042737) | 4.88161752 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 4.87008490 |
| 29 | cysteine metabolic process (GO:0006534) | 4.84828171 |
| 30 | kynurenine metabolic process (GO:0070189) | 4.81065366 |
| 31 | protein-lipid complex assembly (GO:0065005) | 4.78938669 |
| 32 | tryptophan catabolic process (GO:0006569) | 4.77675366 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 4.77675366 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 4.77675366 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.73569925 |
| 36 | acylglycerol homeostasis (GO:0055090) | 4.72496987 |
| 37 | triglyceride homeostasis (GO:0070328) | 4.72496987 |
| 38 | bile acid biosynthetic process (GO:0006699) | 4.58190012 |
| 39 | glyoxylate metabolic process (GO:0046487) | 4.57774417 |
| 40 | flavonoid metabolic process (GO:0009812) | 4.55823170 |
| 41 | lipoprotein metabolic process (GO:0042157) | 4.55051984 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 4.52569924 |
| 43 | cholesterol homeostasis (GO:0042632) | 4.51057222 |
| 44 | tryptophan metabolic process (GO:0006568) | 4.46662930 |
| 45 | sterol homeostasis (GO:0055092) | 4.44907505 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35073505 |
| 47 | cellular glucuronidation (GO:0052695) | 4.34093288 |
| 48 | plasma lipoprotein particle organization (GO:0071827) | 4.34035472 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.33029650 |
| 50 | sulfur amino acid catabolic process (GO:0000098) | 4.32092036 |
| 51 | regulation of fibrinolysis (GO:0051917) | 4.28574302 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.27359878 |
| 53 | phospholipid homeostasis (GO:0055091) | 4.23306277 |
| 54 | regulation of bile acid biosynthetic process (GO:0070857) | 4.23067839 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.21652588 |
| 56 | bile acid metabolic process (GO:0008206) | 4.16113582 |
| 57 | protein-lipid complex subunit organization (GO:0071825) | 4.15285175 |
| 58 | complement activation, alternative pathway (GO:0006957) | 4.13505742 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.10414622 |
| 60 | positive regulation of lipid catabolic process (GO:0050996) | 4.09866081 |
| 61 | protein carboxylation (GO:0018214) | 4.09862287 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.09862287 |
| 63 | regulation of cholesterol homeostasis (GO:2000188) | 4.08338356 |
| 64 | regulation of complement activation (GO:0030449) | 4.01115780 |
| 65 | lysine metabolic process (GO:0006553) | 3.96647436 |
| 66 | lysine catabolic process (GO:0006554) | 3.96647436 |
| 67 | angiotensin maturation (GO:0002003) | 3.95993346 |
| 68 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.93300428 |
| 69 | glucuronate metabolic process (GO:0019585) | 3.93215250 |
| 70 | uronic acid metabolic process (GO:0006063) | 3.93215250 |
| 71 | cholesterol transport (GO:0030301) | 3.90713414 |
| 72 | sterol transport (GO:0015918) | 3.90713414 |
| 73 | aromatic amino acid family metabolic process (GO:0009072) | 3.84422726 |
| 74 | serine family amino acid catabolic process (GO:0009071) | 3.83980726 |
| 75 | glutamate metabolic process (GO:0006536) | 3.81447569 |
| 76 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.75017186 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.69153689 |
| 78 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.68024224 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 3.62094843 |
| 80 | response to nitrosative stress (GO:0051409) | 3.62047270 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.60049229 |
| 82 | arginine metabolic process (GO:0006525) | 3.59606613 |
| 83 | tyrosine metabolic process (GO:0006570) | 3.53154482 |
| 84 | lipid homeostasis (GO:0055088) | 3.52404822 |
| 85 | ethanol oxidation (GO:0006069) | 3.50731663 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 3.50642110 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.47066571 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46917184 |
| 89 | glycine metabolic process (GO:0006544) | 3.46257886 |
| 90 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.43418028 |
| 91 | negative regulation of lipase activity (GO:0060192) | 3.39121782 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.38784544 |
| 93 | drug metabolic process (GO:0017144) | 3.38074201 |
| 94 | coenzyme catabolic process (GO:0009109) | 3.36525634 |
| 95 | drug transmembrane transport (GO:0006855) | 3.35186151 |
| 96 | heme transport (GO:0015886) | 3.35171665 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.34818348 |
| 98 | cellular amino acid catabolic process (GO:0009063) | 3.34062143 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.33434632 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 3.32888546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.25852910 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.57857204 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.12603383 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94849507 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30987294 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.23471895 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.21921375 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73388044 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.51451078 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.13590790 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.77817866 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.24876299 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.18122635 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4670413 |
| 15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.83542465 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.78914252 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.76298234 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74840865 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.67948767 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65862980 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.64244022 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59173046 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52611442 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50527309 |
| 25 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.36024355 |
| 26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.33858017 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22191930 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14598640 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12931591 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12083706 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09586593 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09191837 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00342304 |
| 34 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97592926 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97391022 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97178592 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94634342 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94528232 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94238999 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93715603 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93027737 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91952706 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91057781 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88893075 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88723834 |
| 46 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88489334 |
| 47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84479429 |
| 48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83037652 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80641961 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79875455 |
| 51 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.79096775 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78692181 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78246049 |
| 54 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77620628 |
| 55 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77520265 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75719721 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73018123 |
| 58 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.71264114 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70638392 |
| 60 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70131660 |
| 61 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69912726 |
| 62 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69054233 |
| 63 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.68941263 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.67368497 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66868994 |
| 66 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66716777 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65688325 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65211709 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65211709 |
| 70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64240609 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.63445150 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63150687 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62246481 |
| 74 | ATF3_27146783_Chip-Seq_COLON_Human | 0.62088146 |
| 75 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.60723437 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60320020 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60250886 |
| 78 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59043957 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58932833 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58330788 |
| 81 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57894169 |
| 82 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.57762749 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57535801 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.57138355 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.57084674 |
| 86 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56984497 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56791803 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.55837749 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55730648 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.55718194 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.54899371 |
| 92 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54065730 |
| 93 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53877845 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.53318498 |
| 95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52071748 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51750605 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51497927 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.51330914 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.51287934 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.51276055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.00324343 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.54070381 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.92634646 |
| 4 | MP0005365_abnormal_bile_salt | 5.06280041 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.49641884 |
| 6 | MP0003252_abnormal_bile_duct | 4.39819152 |
| 7 | MP0001666_abnormal_nutrient_absorption | 4.16054777 |
| 8 | MP0009840_abnormal_foam_cell | 3.96293681 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.71626315 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.31695616 |
| 11 | MP0005332_abnormal_amino_acid | 2.49683621 |
| 12 | MP0005083_abnormal_biliary_tract | 2.36726537 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.34370062 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.09091967 |
| 15 | MP0009697_abnormal_copulation | 2.06299017 |
| 16 | MP0000609_abnormal_liver_physiology | 1.94493574 |
| 17 | MP0003195_calcinosis | 1.93481870 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.89496002 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.88746939 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 1.72696519 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 1.60680583 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 1.54560165 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.53295004 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.47499528 |
| 25 | MP0003868_abnormal_feces_composition | 1.46644321 |
| 26 | MP0001764_abnormal_homeostasis | 1.36616983 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.28151351 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24938153 |
| 29 | MP0005451_abnormal_body_composition | 1.19856080 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.10794660 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.06789312 |
| 32 | MP0002254_reproductive_system_inflammat | 1.01892964 |
| 33 | MP0000598_abnormal_liver_morphology | 1.00756266 |
| 34 | MP0003011_delayed_dark_adaptation | 0.97252397 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 0.95907328 |
| 36 | MP0000462_abnormal_digestive_system | 0.92800517 |
| 37 | MP0002822_catalepsy | 0.91697851 |
| 38 | MP0000604_amyloidosis | 0.91518755 |
| 39 | MP0005448_abnormal_energy_balance | 0.86109418 |
| 40 | MP0000537_abnormal_urethra_morphology | 0.86078569 |
| 41 | MP0009764_decreased_sensitivity_to | 0.85633428 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.82506904 |
| 43 | MP0009053_abnormal_anal_canal | 0.82420391 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.79927004 |
| 45 | MP0003186_abnormal_redox_activity | 0.78619244 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 0.77090833 |
| 47 | MP0005408_hypopigmentation | 0.73578952 |
| 48 | MP0008469_abnormal_protein_level | 0.73343145 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.72441446 |
| 50 | MP0000538_abnormal_urinary_bladder | 0.71676557 |
| 51 | MP0009763_increased_sensitivity_to | 0.71064270 |
| 52 | MP0002796_impaired_skin_barrier | 0.69970526 |
| 53 | MP0005266_abnormal_metabolism | 0.69584865 |
| 54 | MP0003718_maternal_effect | 0.68079954 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 0.67052545 |
| 56 | MP0004147_increased_porphyrin_level | 0.66088324 |
| 57 | MP0003300_gastrointestinal_ulcer | 0.65746232 |
| 58 | MP0009384_cardiac_valve_regurgitation | 0.65171512 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.64506379 |
| 60 | MP0005647_abnormal_sex_gland | 0.61516610 |
| 61 | MP0002136_abnormal_kidney_physiology | 0.60506114 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.60113286 |
| 63 | MP0000477_abnormal_intestine_morphology | 0.57551493 |
| 64 | MP0001663_abnormal_digestive_system | 0.57502279 |
| 65 | MP0008872_abnormal_physiological_respon | 0.57381057 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.56856148 |
| 67 | MP0004043_abnormal_pH_regulation | 0.56331093 |
| 68 | MP0005334_abnormal_fat_pad | 0.56262634 |
| 69 | MP0005248_abnormal_Harderian_gland | 0.56092097 |
| 70 | MP0010155_abnormal_intestine_physiology | 0.55298175 |
| 71 | MP0005166_decreased_susceptibility_to | 0.54917500 |
| 72 | MP0005381_digestive/alimentary_phenotyp | 0.51189182 |
| 73 | MP0002928_abnormal_bile_duct | 0.50829798 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.50527039 |
| 75 | MP0002971_abnormal_brown_adipose | 0.49418566 |
| 76 | MP0001756_abnormal_urination | 0.48865344 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.48843994 |
| 78 | MP0009379_abnormal_foot_pigmentation | 0.46727891 |
| 79 | MP0005395_other_phenotype | 0.46418036 |
| 80 | MP0010368_abnormal_lymphatic_system | 0.45049834 |
| 81 | MP0005464_abnormal_platelet_physiology | 0.43591418 |
| 82 | MP0004947_skin_inflammation | 0.43203803 |
| 83 | MP0005535_abnormal_body_temperature | 0.43118992 |
| 84 | MP0003329_amyloid_beta_deposits | 0.42022985 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.41554134 |
| 86 | MP0008873_increased_physiological_sensi | 0.40884283 |
| 87 | MP0010678_abnormal_skin_adnexa | 0.40576674 |
| 88 | MP0003866_abnormal_defecation | 0.40281276 |
| 89 | MP0005501_abnormal_skin_physiology | 0.39416875 |
| 90 | MP0000427_abnormal_hair_cycle | 0.39305317 |
| 91 | MP0001881_abnormal_mammary_gland | 0.38253319 |
| 92 | MP0001664_abnormal_digestion | 0.36895393 |
| 93 | MP0009115_abnormal_fat_cell | 0.36407053 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.36389714 |
| 95 | MP0000249_abnormal_blood_vessel | 0.35374726 |
| 96 | MP0003953_abnormal_hormone_level | 0.33928596 |
| 97 | MP0002060_abnormal_skin_morphology | 0.32547618 |
| 98 | MP0006054_spinal_hemorrhage | 0.32477029 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.32142252 |
| 100 | MP0005165_increased_susceptibility_to | 0.31428586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.65858776 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.82746789 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.29884010 |
| 4 | Xanthomatosis (HP:0000991) | 6.09688230 |
| 5 | Deep venous thrombosis (HP:0002625) | 6.05709085 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.03685982 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.71914106 |
| 8 | Hypolipoproteinemia (HP:0010981) | 5.27637897 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.09305926 |
| 10 | Acanthocytosis (HP:0001927) | 4.75333212 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 4.74370441 |
| 12 | Fat malabsorption (HP:0002630) | 4.71335741 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.61414440 |
| 14 | Epidermoid cyst (HP:0200040) | 4.26801318 |
| 15 | Hyperammonemia (HP:0001987) | 4.20331566 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.18979908 |
| 17 | Complement deficiency (HP:0004431) | 4.18708857 |
| 18 | Hypercholesterolemia (HP:0003124) | 4.15627823 |
| 19 | Hyperglycinuria (HP:0003108) | 4.10622070 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.93173584 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.90417343 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.89079484 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81030257 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.81030257 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.74094896 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.67644002 |
| 27 | Joint hemorrhage (HP:0005261) | 3.51989483 |
| 28 | Ileus (HP:0002595) | 3.48425399 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.47837709 |
| 30 | Malnutrition (HP:0004395) | 3.46472632 |
| 31 | Ketosis (HP:0001946) | 3.44343177 |
| 32 | Hyperbilirubinemia (HP:0002904) | 3.33761231 |
| 33 | Hyperglycinemia (HP:0002154) | 3.32739408 |
| 34 | Poikilocytosis (HP:0004447) | 3.22135748 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 3.19901717 |
| 36 | Hydroxyprolinuria (HP:0003080) | 3.19901717 |
| 37 | Abnormality of complement system (HP:0005339) | 3.08401185 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06668671 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.95690408 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 2.94423457 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91646479 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.86084152 |
| 43 | Ketoacidosis (HP:0001993) | 2.83330834 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.81087982 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.79678991 |
| 46 | Metabolic acidosis (HP:0001942) | 2.78803500 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77170398 |
| 48 | Cholecystitis (HP:0001082) | 2.76024655 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.76024655 |
| 50 | Spontaneous abortion (HP:0005268) | 2.75809076 |
| 51 | Steatorrhea (HP:0002570) | 2.72115926 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.68803587 |
| 53 | Pigmentary retinal degeneration (HP:0001146) | 2.68297267 |
| 54 | Skin nodule (HP:0200036) | 2.67656684 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.62525059 |
| 56 | Vascular calcification (HP:0004934) | 2.61124104 |
| 57 | Esophageal varix (HP:0002040) | 2.52226190 |
| 58 | Myocardial infarction (HP:0001658) | 2.50435725 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.44594259 |
| 60 | Glycosuria (HP:0003076) | 2.44594259 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.39521966 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.38792659 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.35887838 |
| 64 | Cholelithiasis (HP:0001081) | 2.34619018 |
| 65 | Increased mean platelet volume (HP:0011877) | 2.34177719 |
| 66 | Spastic diplegia (HP:0001264) | 2.31290841 |
| 67 | Reticulocytosis (HP:0001923) | 2.30896947 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.30416544 |
| 69 | Late onset (HP:0003584) | 2.28317745 |
| 70 | Gout (HP:0001997) | 2.27805986 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.25493364 |
| 72 | Lethargy (HP:0001254) | 2.24582640 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.22958786 |
| 74 | Abnormality of serum amino acid levels (HP:0003112) | 2.21476986 |
| 75 | Amyloidosis (HP:0011034) | 2.21276634 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.16918873 |
| 77 | Pancreatitis (HP:0001733) | 2.13918698 |
| 78 | Symptomatic seizures (HP:0011145) | 2.11784169 |
| 79 | Abdominal distention (HP:0003270) | 2.11254378 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 2.09302802 |
| 81 | Potter facies (HP:0002009) | 2.08169150 |
| 82 | Facial shape deformation (HP:0011334) | 2.08169150 |
| 83 | Irritability (HP:0000737) | 2.06119837 |
| 84 | Dicarboxylic aciduria (HP:0003215) | 2.05800147 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05800147 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.03980151 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02077948 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.01683809 |
| 89 | Rickets (HP:0002748) | 2.01507216 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01474529 |
| 91 | Gingival bleeding (HP:0000225) | 2.00920076 |
| 92 | Glomerulosclerosis (HP:0000096) | 2.00179695 |
| 93 | Nephrolithiasis (HP:0000787) | 1.95200423 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.93759228 |
| 95 | Polycythemia (HP:0001901) | 1.92640987 |
| 96 | Proximal tubulopathy (HP:0000114) | 1.90726150 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 1.89796172 |
| 98 | Glomerulonephritis (HP:0000099) | 1.88329571 |
| 99 | Confusion (HP:0001289) | 1.84149759 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.83862399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.92724673 |
| 2 | MST1R | 4.05254984 |
| 3 | MST4 | 3.72870802 |
| 4 | EPHA2 | 3.60638416 |
| 5 | ERN1 | 3.43410363 |
| 6 | BCKDK | 3.41551657 |
| 7 | SIK1 | 2.67572045 |
| 8 | PTK6 | 2.55945785 |
| 9 | FGFR4 | 2.55902549 |
| 10 | TAOK3 | 2.44758809 |
| 11 | LMTK2 | 2.39476377 |
| 12 | GRK6 | 2.39254332 |
| 13 | PRKG2 | 2.34716751 |
| 14 | ERBB4 | 2.12526123 |
| 15 | MET | 2.11506456 |
| 16 | MAP3K10 | 1.88222517 |
| 17 | INSRR | 1.75985567 |
| 18 | PKN2 | 1.71440471 |
| 19 | RIPK1 | 1.69892644 |
| 20 | MAP3K2 | 1.67783072 |
| 21 | LATS1 | 1.67608778 |
| 22 | MAP2K2 | 1.56015204 |
| 23 | MAPK11 | 1.50388324 |
| 24 | FLT3 | 1.45838791 |
| 25 | TBK1 | 1.40500101 |
| 26 | PTK2 | 1.30725192 |
| 27 | MAP2K4 | 1.25113993 |
| 28 | TRIB3 | 1.19707607 |
| 29 | MAP3K7 | 1.18158146 |
| 30 | NUAK1 | 1.16211448 |
| 31 | FER | 1.10265298 |
| 32 | PRKAA2 | 1.09301428 |
| 33 | ERBB2 | 1.07455233 |
| 34 | PBK | 1.06880048 |
| 35 | NEK9 | 1.05824187 |
| 36 | EPHB2 | 1.03340032 |
| 37 | NME1 | 1.02867260 |
| 38 | PIK3CG | 1.02251330 |
| 39 | STK10 | 1.02108787 |
| 40 | CDK6 | 0.97250178 |
| 41 | MAP2K6 | 0.92836881 |
| 42 | MAP2K1 | 0.88837653 |
| 43 | MAP3K3 | 0.88424589 |
| 44 | TYK2 | 0.87670917 |
| 45 | DYRK1B | 0.87271513 |
| 46 | ICK | 0.85421225 |
| 47 | EPHB1 | 0.80850260 |
| 48 | MAP3K11 | 0.79168582 |
| 49 | ABL2 | 0.78486505 |
| 50 | MAP3K14 | 0.76516871 |
| 51 | DAPK2 | 0.76305766 |
| 52 | MAP3K8 | 0.75167068 |
| 53 | CSK | 0.67417387 |
| 54 | CAMK2G | 0.67357948 |
| 55 | PRKCQ | 0.66255632 |
| 56 | PDPK1 | 0.65770814 |
| 57 | AKT3 | 0.65661350 |
| 58 | BMX | 0.64650703 |
| 59 | JAK2 | 0.64572272 |
| 60 | AKT2 | 0.64329572 |
| 61 | STK3 | 0.62272089 |
| 62 | PAK4 | 0.58959253 |
| 63 | PDGFRA | 0.57672546 |
| 64 | GSK3A | 0.56669492 |
| 65 | LRRK2 | 0.55704562 |
| 66 | PRKACG | 0.54641408 |
| 67 | PRKAA1 | 0.54590265 |
| 68 | PRKCZ | 0.54515052 |
| 69 | JAK1 | 0.53828542 |
| 70 | PRKCI | 0.51327214 |
| 71 | BCR | 0.49291845 |
| 72 | CAMK1D | 0.48718044 |
| 73 | GRK1 | 0.48220061 |
| 74 | PAK3 | 0.48180335 |
| 75 | MAP3K6 | 0.46175470 |
| 76 | MAP3K1 | 0.46053459 |
| 77 | KDR | 0.44628951 |
| 78 | MAPK4 | 0.43492497 |
| 79 | STK38L | 0.43167632 |
| 80 | MAP3K13 | 0.41698519 |
| 81 | MAPK15 | 0.40650286 |
| 82 | FGR | 0.40126160 |
| 83 | MAP3K5 | 0.39959878 |
| 84 | JAK3 | 0.39869821 |
| 85 | SCYL2 | 0.39271590 |
| 86 | TESK2 | 0.34198299 |
| 87 | PDK1 | 0.33850306 |
| 88 | EGFR | 0.33117330 |
| 89 | PRKCA | 0.29970382 |
| 90 | KSR2 | 0.28950062 |
| 91 | MATK | 0.27090607 |
| 92 | CSNK1G1 | 0.26474328 |
| 93 | DDR2 | 0.25896461 |
| 94 | CSNK1A1L | 0.25501611 |
| 95 | SRC | 0.24698160 |
| 96 | IRAK3 | 0.23452947 |
| 97 | CAMK2B | 0.22494598 |
| 98 | PAK2 | 0.21734819 |
| 99 | PRKCD | 0.21722094 |
| 100 | ABL1 | 0.21416847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53707347 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50308283 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46965340 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.05358924 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92263964 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69601658 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52358797 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47667604 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26714641 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20882680 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19763762 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18285368 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13002821 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.09141067 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07609636 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06581204 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04501495 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01560137 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95225710 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.86914346 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.84730632 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.84006297 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80237170 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73562285 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72357644 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71827969 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.71630432 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66988728 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66146834 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63603646 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.63366480 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59780940 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59404311 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58367433 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57380678 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55744597 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50167982 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36680447 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35927727 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34003685 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30093356 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.28364507 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28327634 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27191665 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24206405 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21905008 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21380706 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20542740 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16983747 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.16770722 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15889615 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11259634 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09260149 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05529993 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03266236 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00682738 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00264725 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99645056 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97896642 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93292352 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.90924652 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88392187 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84752064 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.77164929 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70052918 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69314294 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66846378 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65121139 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65084679 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60855115 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55044248 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53249873 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52514904 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44559051 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44504595 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41293860 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35216101 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26253485 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12070056 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11739595 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.11296676 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.10293025 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.05310581 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04740729 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03510648 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00748876 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00594011 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.00267863 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1881320 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1642842 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | -0.1393684 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1178955 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1066817 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0998439 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0826762 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0817421 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0794965 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.0573221 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0387627 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0063738 |

